Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval
A KCK pharmaceutical company gets a cash injection that should sustain it long enough to get an ADHD drug to the FDA for ...
Yahoo Finance6d
Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
KANSAS CITY, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...